Clinical Trial

Osteogenon in Orthopedics and Traumatology

Study acronym: Osteogenon
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of this study was to evaluate the supportive effect of the ossein-hydroxyapatite complex in fracture healing. The investigators hypothesized that the ossein-hydroxyapatite complex would positively impact fracture healing outcomes.The assessment covers clinical, radiological and biomechanical parameters.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-29.
Trial Details
NCT Number NCT07210281
Lead Sponsor University of Opole
Conditions Patients With Fractures
Enrollment 150 participants
Start Date 2024-11-01
Primary Completion 2027-02-02 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-28